INCLUSION STUDIES ON α-CYCLODEXTRIN COMPLEXES OF GLIPIZIDE AND GLICLAZIDE WITH EFFECT OF PH
DOI:
https://doi.org/10.22159/ajpcr.2017.v10i1.15164Abstract
Objective: To synthesize inclusion complexes of oral antidiabetic drugs, i.e., Glipizide (GP) and Gliclazide (Glc) with a-cyclodextrin (α-CD) and varying the pH which will enhance the solubility and thereby oral bioavailability of the drugs.
Methods: Liquid inclusion complexes were prepared and characterized by ultraviolet-visible (UV-VIS) spectroscopic studies, and fluorescent studies solid inclusion complexes of GP and Glc with α-CD were prepared by co-evaporation method and characterized by differential scanning calorimetric studies (DSC) and1H nuclear magnetic resonance spectroscopic studies (1H NMR).
Results: The inclusion complexes of both GP and Glc with α-CD showed high binding constant values for pH 2 from the UV-VIS spectroscopy studies and fluorescent studies. DSC and1H NMR spectroscopic studies confirmed the inclusion of GP and Glc inside the α-CD cavity.
Conclusion: Formed with more stable inclusion complexes, with α-CD are GP and Glc at pH 2, along with pH modulation could be a suitable strategy to enhance the solubility and oral bioavailability of both the drugs.
Keywords: Solubility, Bioavailability, Glipizide, Gliclazide, Inclusion complexes, α-Cyclodextrin.
Â
Downloads
References
van de Waterbeemd H. The fundamental variables of the biopharmaceutics classification system (BCS): A commentary. Eur J Pharm Sci 1998;7(1):1-3.
Brogden RN, Heel RC, Pakes GE, Speight TM, Avery GS. Glipizide: A review of its pharmacological properties and therapeutic use. Drugs 1979;18(5):329-53.
Zhang YM, Li X, Sun CS, Chen CF. The study on the preparation and spectroscopic properties of hydroxypropyl-beta-cyclodextrin/glipizide inclusion complex. Guang Pu Xue Yu Guang Pu Fen Xi 2008;28(3):711-4.
Zhang S, Nie SF, Wei LI, Liu HF, Pan WS. Study on inclusive reaction of water-soluble β-cyclodextrin polymer with glipizide. Chin Pharm J 2007;42:601.
Shivakumar HN, Desai BG, Pandya S, Karki SS. Influence of beta- cyclodextrin complexation on glipizide release from hydroxypropyl methylcellulose matrix tablets. PDA J Pharm Sci Technol 2007;61(6):472-91.
Ammar HO, Salama HA, Ghorab M, El-Nahhas SA, Elmotasem H. A transdermal delivery system for glipizide. Curr Drug Deliv 2006;3(3):333-41.
Aly AM, Qato MK, Ahmad MO. Enhancement of the dissolution rate and bioavavailability of glipizide through cyclodextrin inclusion complex. Pharm Technol 2003;20:54.
Riekes MK, Tagliari MP, Granda A, Kumine KG. Dissolution rate of amiodarone by complexation with β-cyclodextrin through different methods. Mater Sci Eng 2010;30:1008-13.
Lu Z, Cheng B, Hu Y, Zhang Y, Zou Y. Complexation and antioxidant activity. Food Chem 2009;113:17-20.
Amidon GI, Jinno J, Man OD, Crison JR. Dissolution of ionisable water-insoluble drugs; The combined effect of pH and surfactant. J Pharm Sci 2000;89(82):268-74.
Benesi HA, Hildebrand JH. A spectrophotometric investigation of the interaction of iodine with aromatic hydrocarbons. J Am Chem Soc 1949;71(8):2703.
Bilensoy E, Cirpanli Y, Dogan AL. Thermosensitive mucoadhesive gel formulation loaded with 5-Fu: Cyclodextrin complex for HPV-induced cervical cancer. J Incl Phenom Macrocycl Chem 2007;57:363-70.
Calderini A, Pessine FB. Synthesis and characterization of inclusion complex of the vasodilator drug minoxidel with beta-cyclodextrin. J Incl Phenom Macrocycl Chem 2008;60:369-77.
Cevher E, Sensoy D, Zloh M, Mülazimoglu L. Preparation and characterisation of natamycin: Gamma-cyclodextrin inclusion complex and its evaluation in vaginal mucoadhesive formulations. J Pharm Sci 2008;97(10):4319-35.
Talegaonkar S, Khan AY, Iqbal Z, Khar RK, Ahmed FJ, Khan ZI. Development and characterization of paracetamol complexes with hydroxypropyl-β-cyclodextrin. Iran J Pharm Res 2007;6(2):95-9.
Jadhav GS, Vavia PR. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex. Int J Pharm 2008;352(1-2):5-16.
Sinha VR, Anitha R, Ghosh S, Nanda A, Kumria R. Complexation of celecoxib with beta-cyclodextrin: Characterization of the interaction in solution and in solid state. J Pharm Sci 2005;94(3):676-87.
Rao BP, Sarasija S, Narendra C. Physiochemical characterization of hydroxypropyl - β -cyclodextrin complexes of rifampiein for improved anti-tubercular activity and stability. Indian Drugs 2006;43(8):678-82.
Semalty A, Tanwar SY. Preparation and characterization of cyclodextrin inclusion complexes for improving solubility and dissolution of nimesulide. World J Pharm Sci 2014;2(1):72-8.
Ribeiro LS, Falcão AC, PatrÃcio JA, Ferreira DC, Veiga FJ. Cyclodextrin multicomponent complexation and controlled release delivery strategies to optimize the oral bioavailability of vinpocetine. J Pharm Sci 2007;96(58):2018-28.
Duan MS, Zhao N, Ossurardóttir IB, Thorsteinsson T, Loftsson T. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: Formation of aggregates and higher-order complexes. Int J Pharm 2005;297(1-2):213-22.
McAlpine SR, Garcia-Garibay MA. Binding studies of adamantanecarboxylic acid and a naphthyl-bound beta-cyclodextrin by variable temperature (1)H NMR. J Org Chem 1996;61(23):8307-9.
Bergeron RJ, Channing MA, McGovern KA. Dependence of cycloamylose-substrate binding on charge. J Am Chem Soc 1978;100:2878-83.
Wood DJ, Hruska FE, Sacnger WJ. H-NMR study of the inclusion of aromatic molecules in α-cyclodextrin. J Am Chem Soc 1977;99(6):1735-40.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
